NOVO NORDISK CFO: AS VOLUMES OF WEGOVY, COMPETITOR ELI LILLY'S MOUNJARO CONTINUES TO EXPAND, PRICES WILL GO DOWN
Novo Nordisk Cfo: As Volumes Of Wegovy, Competitor Eli Lilly's…
![Reuters logo](/images/reuters.jpg)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
926.1 DKK | -4.53% |
|
-4.76% | +33.18% |
01:48pm | Novo Nordisk to Update Weight Loss Drugs Labels Over EMA's Safety Recommendation | MT |
10:56am | European shares slide as tech stocks weigh | RE |
NOVO NORDISK CFO: AS VOLUMES OF WEGOVY, COMPETITOR ELI LILLY'S MOUNJARO CONTINUES TO EXPAND, PRICES WILL GO DOWN
1st Jan change | Capi. | |
---|---|---|
+33.18% | 627B | |
+61.53% | 848B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+13.66% | 243B | |
+16.13% | 225B | |
+15.67% | 179B | |
+2.47% | 167B | |
+1.46% | 125B |